Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

621 recalls · Class II, newest first

Class II · Moderate risk

Major Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 0904-6730-60 D-0858-2020
Class II · Moderate risk

Leader Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 7000-0036-1 D-0857-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Terminated Particulate / foreign matter Graviti Pharmaceuticals Private Limited NDC 70377-027-11 D-0832-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Preferred Pharmaceuticals, Inc NDC 68788-7268-01 D-0531-2020
Class II · Moderate risk

Gabapentin Capsules

Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..

Terminated Particulate / foreign matter AuroMedics Pharma LLC NDC 65682-198-99 D-0653-2020
Class II · Moderate risk

fentaNYL 550 mcg/55 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1274-50 D-0572-2020
Class II · Moderate risk

fentaNYL 1500 mcg/30 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1180-79 D-0570-2020
Class II · Moderate risk

fentaNYL 2500 mcg/50 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0569-2020
Class II · Moderate risk

fentaNYL 800 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0568-2020
Class II · Moderate risk

fentaNYL 1000 mcg/20 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1415-47 D-0566-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1103-36 D-0565-2020
Class II · Moderate risk

fentaNYL 400 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1441-76 D-0564-2020
Class II · Moderate risk

fentaNYL 400 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1207-37 D-0562-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1108-36 D-0561-2020

Recalls by year